Copyright
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Feb 26, 2026; 18(2): 114983
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114983
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.114983
Survival outcomes of elderly patients undergoing transcatheter aortic valve implantation after 3 years of follow-up
Abdulaziz Algethami, Mohammed Balghith, Adult Cardiology, King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guard, Riyadh 14611, Ar Riyadh, Saudi Arabia
Abdulaziz Algethami, Salman Salem Alahmadi, Mohammed Balghith, Collage of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh 14611, Ar Riyadh, Saudi Arabia
Abdulaziz Algethami, Mohammed Balghith, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University, Riyadh 14611, Ar Riyadh, Saudi Arabia
Salman Salem Alahmadi, Abdulrahman AlQahtani, King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guard, Ministry of National Guard Health Affairs, Riyadh 14611, Ar Riyadh, Saudi Arabia
Abdulrahman AlQahtani, Department of Cardiology, Taif Health Cluster, At Ta'if 26311, Makkah al Mukarramah, Saudi Arabia
Author contributions: Algethami A and Balghith M designed the report; Alahmadi SS collected the patient’s clinical data; AlQahtani A analyzed the data and wrote the paper; all authors read and approved the final manuscript.
Institutional review board statement: This study was approved by the Institutional Review Board of King Abdullah International Medical Research Center.
Informed consent statement: Due to the retrospective design, the requirement for informed consent was waived. All data were anonymized prior to analysis, and patient privacy and confidentiality were strictly maintained in accordance with institutional and international ethical standards (Declaration of Helsinki).
Conflict-of-interest statement: The authors declare no conflicts of interest.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement:
The datasets generated and/or analyzed during the current study are not publicly available due to institutional restrictions and patient privacy concerns but are available from the corresponding author on reasonable request and with permission from King Abdullah International Medical Research Center.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Abdulrahman AlQahtani, MD, Department of Cardiology, Taif Health Cluster, Government Complex, City Center, At Ta'if 26311, Makkah al Mukarramah, Saudi Arabia. a.s.alqahtni@gmail.com
Received: October 11, 2025
Revised: October 25, 2025
Accepted: December 12, 2025
Published online: February 26, 2026
Processing time: 128 Days and 17.4 Hours
Revised: October 25, 2025
Accepted: December 12, 2025
Published online: February 26, 2026
Processing time: 128 Days and 17.4 Hours
Core Tip
Core Tip: Transcatheter aortic valve implantation (TAVI) demonstrated favorable mid-term survival in our cohort of elderly patients aged 85 years or older. The 1-year and 3-year survival rates were 82% and 63%, respectively. Mortality risk increased in patients with obesity. Advanced age alone should not be a contraindication for TAVI.